StocksFin Logo
ABBV logo
$ABBV

AbbVie Inc.

ABBV country of incorporation
|
https://www.abbvie.com
|
Mr. Richard Gonzalez
|
50,000 employees
NYSE | Healthcare | Drug Manufacturers—General
ABBV reported its Q322 earnings on November 4, 2022 (90 weeks ago).
$14.81B 3.3% vs. Q321 Revenues Q322
66.1% -4.7% vs. Q321 Gross Profit Margin
26.66% 20.3% vs. Q321 Net Profit Margin
7.43B -3.8% vs. Q321 Free Cash Flow Q322
$2.22 23.4% vs. Q321 EPS Q322
Company Card Q322
As reported on November 4, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B+
Growth calculated YoY
Company Card Q322
As reported on November 4, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B+
Growth calculated YoY
Overview
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
14.81B
+1.6%
5.02B
3.95B
+327.4%
$2.22
Q22022
14.58B
+7.7%
4.17B
924M
-79.4%
$0.52
Q12022
13.54B
4.05B
4.49B
$2.52
FY2021
56.2B
 17.45B
11.54B
$6.53
Q42021
14.89B
+3.8%
4.32B
4.04B
+27.2%
$2.29
Q32021
14.34B
+2.7%
4.39B
3.18B
+315%
$1.8
Q22021
13.96B
+7.3%
4.52B
766M
-78.4%
$0.43
Q12021
13.01B
4.21B
3.55B
$2.01
FY2020
45.8B
 15.39B
4.62B
$2.62
FY2019
33.27B
 7.44B
7.88B
$5.33
FY2018
32.75B
 7.72B
5.69B
$3.85
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
141.33B
 125.3B
11.83B
69.61B
15.99B
Q22022
143.19B
 128.5B
8.52B
72.93B
14.65B
Q12022
143.21B
 126.9B
6.1B
73.47B
16.28B
FY2021
146.53B
 131.09B
9.75B
89.18B
15.41B
FY2020
150.57B
 137.47B
8.45B
94.56B
13.08B
FY2019
89.12B
 97.29B
39.92B
70.48B
-8.17B
FY2018
59.35B
 67.8B
7.29B
45.62B
-8.45B
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
7.6B
 1.29B
-5.52B
-177M
7.43B
+52.7%
Q22022
5.01B
 130M
-2.68B
-143M
4.86B
+2.4%
Q12022
4.91B
 -1.59B
-6.97B
-162M
4.75B
FY2021
22.78B
 -2.34B
-19.04B
-787M
21.99B
FY2020
17.59B
 -37.56B
-11.5B
-798M
16.79B
FY2019
13.32B
 596M
18.71B
-552M
12.77B
FY2018
13.43B
 -1.01B
-14.4B
-638M
12.79B
Institutional Ownership
Dividend History
Date Amount
Oct 13, 2022 $1.41
Jul 14, 2022 $1.41
Apr 13, 2022 $1.41
Jan 13, 2022 $1.41
Oct 14, 2021 $1.3
Jul 14, 2021 $1.3
Apr 14, 2021 $1.3
Jan 14, 2021 $1.3
Number of Employees